1-9 of 9
Joanna Niesiobedzka-Krezel
Close
Sort by
Journal Articles

A Multicenter Prospective Study on Efficacy and Safety of Ponatinib in Patients with Chronic Myeloid Leukemia Resistant or Intolerant to Previous Therapy: A 3-Year Report

Tomasz Sacha, MDPhD, Elzbieta Szczepanek, Paulina Dumnicka, PhD, Joanna Gora-Tybor, MD PhD, Joanna Niesiobedzka-Krezel, MDPhD, Witold Prejzner, MD PhD, Ewa Wasilewska, MDPhD, Janusz Kloczko, MDPhD, Hanna Ciepluch, MD, Wioletta Makowska, MD, Elzbieta Patkowska, MD, Joanna Wasilewska, MD, Grazyna Bober, MD, Malgorzata Kopera, MDPhD, Ryszard Wichary, MD, Renata Kroll-Balcerzak, MDPhD, Tomasz Gromek, MDPhD, Malgorzata Wach, MDPhD, Anna Rudkowska-Kazanowska, MD, Magdalena Swiniarska, MD, Edyta Paczkowska, MDPhD, Ewa Medras, MD, Monika Joks, MD, Marta Oller, MD, Renata Kasza, MD, Aleksandra Kostyra, MD, Justyna Gil, MD, Olga Grzybowska-Izydorczyk, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-141523
Published: 2020
Journal Articles

Analysis of Predictive Factors for Early Response to Ruxolitinib in 266 Patients with Myelofibrosis from the Polish Adult Leukemia Group (PALG) Registry

Joanna Gora Tybor, MD PhD, Aleksandra Golos, MD PhD, Tomasz Sacha, MD PhD, Krzysztof Lewandowski, MD PhD, Joanna Niesiobedzka-Krezel, MD PhD, Maria Bieniaszewska, Hubert Wysoglad, Olga Grzybowska-Izydorczyk, Ilona Seferynska, MD PhD, Marta Sobas, MD, Maria Czyżewska, Agnieszka Michalska, Waldemar Sawicki, MD PhD, Malwina Mazur, Marek Hus, MD PhD, Ewa Bodzenta, Magdalena Olszewska-Szopa, Elżbieta Patkowska, Wojciech Świstek, Krzysztof Jamroziak, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4180.
https://doi.org/10.1182/blood-2019-125864
Published: 2019
Journal Articles

ASXL1 Mutations Detectable at Diagnosis May Predict Response to Imatinib in Patients with Chronic Myeloid Leukemia

Marcin M Machnicki, MSc, Monika Pepek, MSc, Iwona Solarska, PhD, Joanna Niesiobedzka-Krezel, MD PhD, Ilona Seferynska, MD PhD, Joanna Gora Tybor, MD PhD, Magdalena Zawada, PhD, Tomasz Sacha, MD PhD, Waldemar Sawicki, MD PhD, Ewa Wasilewska, MD PhD, Katarzyna Pruszczyk, MD, Malgorzata Rydzanicz, PhD, Rafal Ploski, MD PhD, Tomasz Skorski, MD PhD, Tomasz Stoklosa, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4148.
https://doi.org/10.1182/blood-2019-129834
Published: 2019
Journal Articles

Concomitant Medications and Comorbidities Affect Early Response in CML Patients Treated with Imatinib: A Retrospective Analysis of 340 Patients from the Polish Adult Leukemia Group (PALG) Registry

Joanna Gora Tybor, Tomasz Sacha, Joanna Waclaw, Joanna Niesiobedzka-Krezel, Olga Grzybowska-Izydorczyk, Ewa Medras, Izabela Deren-Wagemann, Elzbieta Patkowska, Ilona Seferynska, Krzysztof Lewandowski, Anna Wache, Beata Blajer-Olszewska, Marzena Watek, Ewa Wasilewska, Tomasz Stoklosa, Krzysztof Warzocha, Krzysztof Jamroziak
Journal: Blood
Blood (2017) 130 (Supplement 1): 2887.
https://doi.org/10.1182/blood.V130.Suppl_1.2887.2887
Published: 2017
Journal Articles

Imatinib Generics in Treatment of Chronic Myeloid Leukemia; A Prospective Observation in Large Cohort of Patients from Polish (PALG) Imatinib Generics Registry

Tomasz Sacha, Joanna Gora-Tybor, Monika Szarejko, MD PhD, Grażyna Bober, MD, Olga Grzybowska-Izydorczyk, Joanna Niesiobędzka-Krężel, MD, Marek Dudziński, MD, Ewa Wasilewska, MD PhD, Krzysztof Myśliwiec, MD, Justyna Gil, MD PhD, Michał Gniot, MD PhD, Iwona Pietkun, MD, Ewa Mędraś, MD PhD, Joanna Wącław, MD, Krzysztof Giannopoulos
Journal: Blood
Blood (2016) 128 (22): 629.
https://doi.org/10.1182/blood.V128.22.629.629
Published: 2016
Journal Articles

Differential Expression of BIRC Family Genes In The Course Of Chronic Myeloid Leukemia – BIRC3 and BIRC8 As Potential New Candidates To Identify Disease Progression

Eliza Glodkowska-Mrowka, MD, Iwona Solarska, PhD, Piotr Mrowka, PhD, Katarzyna Bajorek, MSc, Joanna Niesiobedzka-Krezel, MD, Ilona Seferynska, MD, PhD, Katarzyna Borg, PhD, Tomasz Stoklosa, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2718.
https://doi.org/10.1182/blood.V122.21.2718.2718
Published: 2013
Journal Articles

Targeting Rac2 - Mitochondrial Respiratory Chain Complex III Signaling to Prevent Genomic Instability in Leukemia Stem and Progenitor Cells

Margaret Nieborowska-Skorska, MD, PhD, Piotr Kopinski, Regina Ray, Grazyna Hoser, PhD, Danielle Ngaba, Sylwia Flis, Kimberly Cramer, Mamatha M. Reddy, PhD, Mateusz Koptyra, PhD, Tyrone Penserga, Eliza Glodkowska-Mrowka, MD, Magdalena Ambrozek, Ilona Seferynska, MD, PhD, Joanna Niesiobedzka-Krezel, MD, Elisabeth Bolton, Artur Slupianek, PhD, Tessa L. Holyoake, PhD, FRCP, FRCPath, Connie J. Eaves, PhD, Sabine Cerny-Reiterer, D.V.M., Peter Valent, M.D., Andreas Hochhaus, MD, Timothy P. Hughes, MD, MBBS, Heiko van der Kuip, Martin Sattler, PhD, Wieslaw Wiktor-Jedrzejczak, MD, PhD, Christine Richardson, PhD, Adrienne M. Dorrance, PhD, Tomasz Stoklosa, MD, PhD, David A. Williams, MD, Tomasz Skorski, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2736.
https://doi.org/10.1182/blood.V118.21.2736.2736
Published: 2011
Journal Articles

Statins Increase Antileukemic Potency of Imatinib Through the Inhibition of MDR/ABCB1 and BCRP/ABCG2 Drug Transporters Activity

Eliza Glodkowska-Mrowka, MD, Piotr Mrowka, M.Sc., Magdalena Winiarska, PhD, Grzegorz Basak, MD, PhD, Joanna Niesiobedzka-Krezel, MD, Ilona Seferynska, MD, PhD, Pawel Krzysztof Wlodarski, MD, PhD, Marek Jakobisiak, MD, PhD, Tomasz Stoklosa, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2742.
https://doi.org/10.1182/blood.V118.21.2742.2742
Published: 2011
Journal Articles

Potentiation of the Antileukemic Effects of Imatinib through the Modulation of BCRP/ABCG2 Activity.

Eliza Glodkowska-Mrowka, MD, Magda Winiarska, PhD, Piotr Mrowka, M.Sc., Grzegorz Basak, MD, PhD, Joanna Niesiobedzka-Krezel, MD, Ilona Seferynska, MD, PhD, Tomasz Stoklosa, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3400.
https://doi.org/10.1182/blood.V116.21.3400.3400
Published: 2010